CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,821,711
- in 1 filing, $4.8M under 10b5-1 plans
Net −$4,821,711. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −1,505 | $78.56 | $118K | 100,700 |
| 2026-11-05 | Kennedy Keith CFO & COO | Option exercise 10b5-1 | +52,422 | $29.43 | $1.5M | 261,108 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −28,256 | $76.55 | $2.2M | 232,852 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −12,380 | $77.42 | $958K | 220,472 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −6,897 | $78.59 | $542K | 213,575 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −7,415 | $79.49 | $589K | 206,160 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −3,403 | $80.38 | $274K | 202,757 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −2,710 | $81.40 | $221K | 200,047 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −300 | $82.08 | $25K | 199,747 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −600 | $83.60 | $50K | 199,147 |
| 2026-11-05 | Kennedy Keith CFO & COO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −52,422 | 48,229 | ||
| 2026-11-03 | Cohen Fred E Director | Gift | −25,000 | 140,060 | ||
| 2026-11-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,873 | $85.88 | $247K | 102,205 |
| 2026-10-02 | Goldberg Michael Director | Grant or award | +588 | 62,326 | ||
| 2026-10-01 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −2,619 | $66.23 | $173K | 158,980 |
| 2026-10-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −997 | $66.23 | $66K | 105,078 |
| 2026-10-01 | Hanna John Walter JR President and CEO | Shares withheld for taxes | −8,511 | $66.23 | $564K | 644,937 |
| 2026-10-01 | Kennedy Keith CFO & COO | Shares withheld for taxes | −3,018 | $66.23 | $200K | 208,686 |
| 2026-09-12 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −6,688 | $52.37 | $350K | 161,599 |
| 2026-09-12 | Kennedy Keith CFO & COO | Shares withheld for taxes | −8,220 | $52.37 | $430K | 211,704 |
Page 1 of 16 · 319 trades